Orsil Pharmaceuticals LLP
About Orsil Pharmaceuticals LLP
Data last updated:
Orsil Pharmaceuticals LLP is a limited liability partnership (LLP) based in Ahmadabad City, Gujarat, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 25 January 2019 and has been in existence for over 7 years.
The LLP is registered with the Registrar of Companies (ROC), Ahmedabad, under LLPIN AAO-1318. Its GSTIN is 24AAGFO3162K1Z8 (Gujarat).
The LLP has a total obligation of contribution of ₹3 Lakh. It is led by designated partners Mayurbhai Navinbhai Pandya and Nimisha Vishal Sheth.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Sumel Business Park, Ahmadabad City, Gujarat.
As per MCA filings, the LLP has open charges of ₹33.54 Lakh on record.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address319 3rd Floor Block – D Tps – 14, Sumel Business Park – 6 Nr. Dudheswar Circle, Ahmadabad City, Gujarat, India – 380004
- IndustryPharma, Drug Formulation & Development
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Financials of Orsil Pharmaceuticals LLP FY 2025 filings available
Financial Statement Summary of Orsil Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Income | •••• | •••• | •••• | •••• | •••• |
| Purchases and Direct Costs | •••• | •••• | •••• | •••• | •••• |
| Personnel Expenses | •••• | •••• | •••• | •••• | •••• |
| Administrative Expenses | •••• | •••• | •••• | •••• | •••• |
| Interest | •••• | •••• | •••• | •••• | •••• |
| Depreciation | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax | •••• | •••• | •••• | •••• | •••• |
| Profit After Tax | •••• | •••• | •••• | •••• | •••• |
| Profit Transferred to Partners | •••• | •••• | •••• | •••• | •••• |
| Assets and Liabilities | |||||
| Partners' Contribution | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Secured Loans | •••• | •••• | •••• | •••• | •••• |
| Unsecured Loans | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Other Liabilities and Provisions | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Loans and Advances | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Orsil Pharmaceuticals LLP
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | •••• | •••• | •••• | •••• | •••• |
| Return on Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Return on Assets | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt to Partners' Funds | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Turnover Growth | •••• | •••• | •••• | •••• | •••• |
| Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form 8. The full year-wise statements and ratios of Orsil Pharmaceuticals are in the company report.
Financial statements from FY 2019
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Designated Partners of Orsil Pharmaceuticals LLP
Orsil Pharmaceuticals has 2 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mayurbhai Navinbhai Pandya | Designated Partner | 25 Jan 2019 | 7 Years 8 Months | Current |
| Nimisha Vishal Sheth | Designated Partner | 25 Jan 2019 | 7 Years 8 Months | Current |
Charges & Borrowings of Orsil Pharmaceuticals LLP
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Jun 2025 | Nutan Nagarik Sahakri Bank Limited | ₹15 Lakh | Open |
| 20 Jun 2025 | Nutan Nagarik Sahakri Bank Limited | ₹18.54 Lakh | Open |
Total charge records: 2 View all charges
Employees and EPFO Compliance at Orsil Pharmaceuticals LLP
Employment history and EPFO contributions of people linked to Orsil Pharmaceuticals.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Orsil Pharmaceuticals LLP
Orsil Pharmaceuticals LLP has 3 designated partner changes on record since 2019: 2 appointments and 1 cessation. The latest: Jiten Girish Pandya ceased to be Designated Partner on 01 Feb 2024.
Credit Ratings, Litigation & Regulatory Alerts for Orsil Pharmaceuticals LLP
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Orsil Pharmaceuticals LLP
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Orsil Pharmaceuticals LLP
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Orsil Pharmaceuticals LLP
Orsil Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 24AAGFO3162K1Z8 | Gujarat | Active | 05 Apr 2019 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Orsil Pharmaceuticals LLP
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Orsil Pharmaceuticals LLP
Orsil Pharmaceuticals is an active limited liability partnership based in Ahmadabad City, Gujarat, India. The LLP works in drug formulation and development, within the pharma industry. It was incorporated on 25 January 2019 (7+ years old) and is registered under LLPIN AAO-1318.
Orsil Pharmaceuticals has 2 current designated partners:
- Mayurbhai Navinbhai Pandya - Designated Partner
- Nimisha Vishal Sheth - Designated Partner
The GSTIN of Orsil Pharmaceuticals is 24AAGFO3162K1Z8, registered in Gujarat.
The LLPIN (Limited Liability Partnership Identification Number) of Orsil Pharmaceuticals is AAO-1318. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Orsil Pharmaceuticals was incorporated on 25 January 2019, making it 7+ years old. It is registered with the Registrar of Companies, Ahmedabad.
Jiten Girish Pandya ceased to be Designated Partner on 01 Feb 2024. Mayurbhai Navinbhai Pandya was appointed as Designated Partner on 25 Jan 2019. Nimisha Vishal Sheth was appointed as Designated Partner on 25 Jan 2019.
The registered office of Orsil Pharmaceuticals is at 319 3rd Floor Block – D Tps – 14, Sumel Business Park – 6 Nr. Dudheswar Circle, Ahmadabad City, Gujarat, India – 380004.
The total obligation of contribution is ₹3 Lakh.
Orsil Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Orsil Pharmaceuticals has open charges of ₹33.54 Lakh and no satisfied charges on record as per latest MCA filings.